Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Gain of Adding the Immunomodulator Pentoxifylline to the Treatment of Cutaneous Leishmaniasis

NCT01464242 is registered in ClinicalTrials.gov with Centro Internacional de Entrenamiento e Investigaciones Médicas as lead sponsor.

NCT NCT01464242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01464242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Gain of Adding the Immunomodulator Pentoxifylline to the Treatment of Cutaneous Leishmaniasis
Lead sponsor
Centro Internacional de Entrenamiento e Investigaciones Médicas
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2011
Completion date
December 31, 2015
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis